Company Overview

Zentek Ltd. (OTCQB: ZTEKF; TSXV: ZEN) is a Canadian technology development company focused on graphene-based and nanomaterial-enhanced products for industrial, healthcare, and environmental applications. The company operates primarily in the advanced materials and nanotechnology sectors, with commercial and pre-commercial initiatives involving graphene-enhanced coatings, corrosion protection technologies, air filtration systems, antimicrobial materials, and ice-phobic solutions. Zentek’s business strategy centers on developing intellectual property and commercializing proprietary graphene formulations through partnerships, licensing arrangements, and product integration opportunities.

Historically, the company began as a mineral exploration business associated with the Albany graphite deposit in Northern Ontario, which remains one of its notable strategic assets. Over time, Zentek transitioned from a resource-focused company into a technology development enterprise emphasizing graphene applications derived from its materials expertise. The company’s positioning is tied to its vertically integrated understanding of graphene production, intellectual property development, and collaborations with research institutions and industrial partners in Canada and abroad.

Business Operations

Zentek’s operations are organized around graphene-enhanced technologies and intellectual property commercialization. Key business activities include the development of the company’s proprietary ZenGUARD™ technology platform, which has been applied to antimicrobial coatings and filtration products. The company has pursued commercial opportunities in personal protective equipment, HVAC filtration systems, corrosion-resistant coatings, and industrial materials enhancement. Revenue generation has historically been limited relative to larger industrial peers, with the company remaining primarily in a development and commercialization stage according to public filings and investor disclosures.

The company maintains operations principally in Canada while pursuing broader commercialization opportunities internationally. Zentek controls intellectual property related to graphene synthesis, coatings, and nanomaterial applications, supported by patent filings and research collaborations. Major strategic relationships have included partnerships with academic institutions, healthcare organizations, and manufacturing counterparties to support product testing and commercialization. The Albany graphite deposit, historically associated with the company’s origins, remains an important long-term asset connected to potential graphene feedstock development.

Strategic Position & Investments

Zentek’s strategic direction emphasizes commercialization of graphene-enabled technologies across healthcare, infrastructure, industrial protection, and environmental markets. Growth initiatives have focused on scaling the ZenGUARD™ platform, expanding regulatory approvals for filtration and antimicrobial applications, and advancing corrosion mitigation technologies intended for industrial and transportation infrastructure. The company has also explored applications involving ice-phobic coatings and energy-related materials technologies.

The company’s investments have largely centered on research and development, patent protection, pilot manufacturing capabilities, and collaborative commercialization agreements rather than large-scale acquisitions. Zentek has continued investing in intellectual property development tied to nanomaterials and graphene-enhanced solutions. Its strategic advantage is frequently associated with early-stage specialization in graphene application technologies and its ownership interest in the Albany graphite deposit, which has been described in public technical disclosures as a potentially unique hydrothermal graphite resource.

Geographic Footprint

Zentek is headquartered in Guelph, Ontario, Canada, and its operations are concentrated primarily within Canada. The company’s research, product development, and commercialization activities have involved collaborations with Canadian universities, laboratories, healthcare organizations, and industrial manufacturers. Its principal market presence remains in North America, particularly in sectors connected to healthcare technologies, industrial coatings, and advanced materials.

Internationally, Zentek has pursued commercial outreach and intellectual property positioning in broader global markets for graphene-enabled technologies. While the company does not currently operate extensive multinational industrial facilities, it has indicated strategic interest in applications relevant to markets in Europe, the United States, and other regions where demand exists for advanced filtration, antimicrobial protection, and materials performance technologies. Public disclosures indicate that the company’s global influence is presently more technology- and IP-oriented than manufacturing-scale in nature.

Leadership & Governance

Zentek’s leadership team has emphasized transitioning the company from a mineral exploration entity into a commercial nanotechnology and advanced materials business. Management strategy has focused on intellectual property development, commercialization partnerships, and regulatory advancement of graphene-enhanced technologies. Corporate governance and strategic communications are guided through public filings, investor presentations, and disclosures made through Canadian securities regulators and OTC market reporting requirements.

Key executives and leadership figures include:

• Greg Fenton – Chief Executive Officer
• Vivek Dave – Chief Financial Officer
• Francis Dubé – Chairman
• Ryan Shacklock – Vice President, Strategy & Business Development
• Brett Richards – Former Chief Executive Officer and former strategic leadership figure during the company’s transition period

The company’s governance approach reflects a technology commercialization model supported by scientific advisory input, intellectual property development, and capital market financing typical of emerging advanced materials companies listed on Canadian venture exchanges.